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1078–5884/00The Prevalence of Chronic Critical Lower Limb Ischaemia
in a Population of 20,000 Subjects 40–69 Years of Age
S.A. Jensen,1,2 L.J. Vatten3 and H.O. Myhre1,2*Departments of 1Circulation and Medical Imaging, Faculty of Medicine, University Medical Center,
Norwegian University of Science and Technology, N-7489 Trondheim, 2Surgery, St Olavs Hospital, University
Hospital of Trondheim, Olav Kyrres Gate 17, N-7006 Trondheim, and 3Public Health, University Medical
Center, Norwegian University of Science and Technology, N-7489 Trondheim, NorwayObjective. To study the prevalence and possible risk factors for chronic critical lower limb ischaemia (CLI) in an unselected
population of 20,291 Norwegian men and women 40–69 years of age.
Methods. Between 1995 and 1997, all residents 20 years or older in Nord-Trøndelag County, Norway, were invited to
participate in a population study (the HUNT 2 Study). Among the 71.2% who attended, 20,291 participants 40–69 years of
age responded to questions specifically aimed at identifying CLI. Chronic critical ischaemia was suspected if participants
indicated: (1) ulcers on toes, foot or ankle that had failed to heal and/or; (2) persistent pain in the forefoot while in the supine
position, but with relief of this pain when standing up. Using logistic regression analyses, we estimated the association
between the prevalence of CLI and smoking, diabetes mellitus, previous cardiovascular events, blood lipids and glucose
levels, and body mass index (BMI).
Results. The age-adjusted prevalence of CLI was 0.26% among men and 0.24% among women, and there was no gender
difference in any age group (age-adjusted ORZ0.91, 95% CIZ0.52–1.58). The presence of increased age, diabetes mellitus,
angina pectoris, high triglyceride levels, and high BMI were all independently associated with higher prevalence of CLI.
Conclusion. The prevalence of CLI was 0.24%, similar for both genders, and increased with age. Risk factors usually seen in
atherosclerotic patients were associated with suspected CLI.Keywords: Peripheral arterial disease; Epidemiology; Population study; Prevalence; Association.Introduction
Chronic critical lower limb ischaemia (CLI) is a serious
condition if left untreated. Over 25% of CLI patients
will require major amputation, but reconstructive
arterial surgery improves limb salvage.1–4 Although
surgical interventions are costly, they have proven
cost-effective compared to conservative treatment.5–8
Nevertheless, mortality is expected to be 20% within
the first year of presentation, and 40–75% are likely to
die within 5 years.3,9,10 The occurrence of CLI has been
studied by inference made from major amputations
and CLI hospitalization rates. Others have studied the
progression to CLI in patients with intermittent
claudication.3,4,11–17 Although these estimates areing author. Professor Hans O. Myhre, MD, PhD,
of Surgery, St Olavs Hospital, University Hospital of
lav Kyrres Gate 17, N-7006 Trondheim, Norway.
: hans.myhre@ntnu.no
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able populations have yielded fairly similar estimates
of the disease frequency.12,17 Thus, reports on
incidence of CLI have ranged from 500 to 1000 per
million inhabitants per year, and the prevalence has
been estimated to be 1 per 2500 inhabitants.12,13,17
However, some CLI patients may never be hospital-
ized, and the true prevalence may only be obtained in
population based studies.18
Critical lower limb ischaemia is recognized in
patients with persistent ischaemic pain of more than
14 days duration requiring analgesia and/or charac-
terized by tissue loss due to ischaemia.8,13,15 The
Fontaine and the Rutherford classifications seek to
identify patients with lower limb ischaemia including
CLI.5,8 However, these classifications do not include a
clear definition of CLI, rely on trained personnel for
the diagnosis, and require the use of ankle brachial
pressure index, ABPI, as an objective outcomeEur J Vasc Endovasc Surg 32, 60–65 (2006)
doi:10.1016/j.ejvs.2005.12.022, available online at http://www.sciencedirect.com onved.
Prevalence of Critical Lower Limb Ischaemia 61measure.14,15,19 Such objective diagnostic tests are
costly and in larger population surveys simple screen-
ing tests are easier to use.13–15,19,20
The aim of this study was to use a questionnaire to
estimate the prevalence of CLI in an unselected
population of 20,291 Norwegian men and women
between 40 and 69 years of age. Further, we studied
the association between risk factors for atherosclerotic
disease in relation to the prevalence of suspected CLI.Patients and MethodsThe study population
Between 1995 and 1997 all residents 20 years or older
in Nord-Trøndelag County, Norway, were invited to
participate in a health study called HUNT 2
(Helseundersøkelsen i Nord-Trøndelag: HUNT 2).21
71.2% (66,140) of those invited attended and all
participants responded to a brief questionnaire
enclosed with the invitation. They also underwent a
physical examination and received a second ques-
tionnaire that was to be completed at home and
returned by mail. The clinical examination included
measurements of height, weight, brachial blood
pressure, and a sample of venous blood was collected.
The second questionnaire was handed to participants
aged 20–69 years of age and included questions
designed to identify individuals with CLI. Participants
70 years of age and older did not receive the second
questionnaire. Since, CLI is very rare at a young age,
we restricted the analysis to participants 40–69 years of
age and thus, the study population consisted of 9640
men and 10,651 women.The diagnosis of CLI
We constructed a simple questionnaire that was based
only on symptoms or signs of the disease, and to fulfill
the criteria of suspected CLI, participants should
answer yes to one or both of the following questions:
(1) Do you have ulcers on toes, foot or ankle that have
failed to heal?; (2) Do you have persistent pain in the
forefoot while in the supine position, but with relief of
the pain when standing up?Study factors
Individuals who had never smoked cigarettes daily
were considered never smokers, and those who
reported previous or current daily smoking wereclassified as former or current smokers, respectively.
For the regression analyses, smoking was categorized
into current, former, or never smokers. History of
diabetes mellitus (both insulin-dependent and non-
insulin-dependent), previous myocardial infarction
(MI), and current or previous angina pectoris were
obtained from the questionnaire. The variables were
dichotomized for the regression analyses. Non-fasting
blood glucose levels (millimole per litre) were
measured in sera obtained at the examination.21
Further, in diabetic patients, analyses of HbA1c levels
(milligram percentage) were performed. These two
variables were divided at the median for the statistical
analyses. Concentrations of total serum cholesterol
(TC) were measured by the Liebermann–Buchard
method, and triglyceride concentrations by a fluori-
metric method.22 High density lipoprotein (HDL) was
determined with a heparin–manganese method.22
Each variable (total cholesterol, HDL–cholesterol and
triglycerides) was categorized into two approximately
equal groups using the median as cut point and
included in the regression model as a categorical
variable. Recordings of height (in centimetre) and
weight (in kilogram) were standardized and per-
formed by trained personnel. Body mass index (BMI)
was computed as weight (in kilogram) divided by the
height (in metre) squared. The variable was categor-
ized into two approximately equal groups before
inclusion in the regression model.Statistical analyses
Age adjustment for the total prevalence of CLI among
men and women was calculated using the direct
method with the total HUNT 2 study population
between 40 and 69 years of age as the reference
standard. Gender differences in the prevalence of CLI
were investigated by age-adjusted prevalence ratios,
and precision of the ratios was estimated with 95%
confidence interval (CI). Associations between the
prevalence of CLI and smoking, diabetes mellitus,
blood lipids and glucose levels, previous cardiovas-
cular events and BMI were investigated using logistic
regression analyses. Age was included in the
regression model and the variable divided into
5-year categories to produce age-adjusted prevalence
odds ratios (OR) with 95% confidence intervals
(95% CI). The effect of potential confounding by
smoking, diabetes and blood lipids was assessed in
subsequent multivariate analyses by comparing age-
adjusted and multivariate adjusted estimates. All
statistical analyses were performed using theEur J Vasc Endovasc Surg Vol 32, July 2006
Table 1. The prevalence of chronic critical lower limb ischaemia in men and women 40–69 years of age
Age Men Women Total
CLI Participants Prevalence (%) CLI Participants Prevalence (%) CLI Participants Prevalence (%)
40–49 8 3860 0.21 4 4420 0.09 12 8280 0.14
50–59 8 3264 0.25 10 3575 0.28 18 6839 0.26
60–69 9 2516 0.36 11 2656 0.41 20 5172 0.39
Total 25 9640 0.26* 25 10,651 0.24* 50 20,291 0.24*
* Age adjusted prevalence.
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(Release 13.00, Copyright SPSS, Inc., 1989–2005).0.00
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Fig. 1. The prevalence of chronic critical lower limb
ischaemia in men and women 40–69 years of age increased
by age.Results
The age-adjusted prevalence of CLI in the total
population was 0.24% (Table 1), 0.26% for men and
0.24% for women. We observed no gender differences
in any age group. The ratio between women and men
was 0.91 (95% CI, 0.52–1.58), and the prevalence
increased with age in both genders (Fig. 1).
Current smoking showed no association with the
prevalence of CLI when compared to former and
never smokers (ORZ1.2; 95% CIZ0.6–2.2, Table 2).
However, the prevalence of CLI was substantially
higher in former and current smokers compared to the
occurrence of disease among never smokers (ORZ2.3;
95% CIZ1.1–4.6).
CLI was 4.4 times more common among people
with diabetes compared to the general population
(ORZ4.4; 95% CIZ1.9–10.5). There was also a
tendency that previous cardiovascular events were
more common among the CLI subjects: they were
nearly twice as likely to have suffered from myocardial
infarction (ORZ1.8; 95% CIZ0.6–5.2), and nearly
three times more likely to have angina pectoris
(ORZ2.7; 95% CIZ1.0–7.6), compared to the general
population.
Subjects with serum total cholesterol concentrations
higher than 6.0 mmol/L had an OR of 1.6 (95% CIZ
0.9–3.0) compared to subjects with TC concentrations
less than 6.0 mmol/L. Further, CLI was more likely in
subjects with serum triglyceride concentrations higher
than 1.50 mmol/L compared to lower TG levels (ORZ
2.1; 95% CIZ1.2–4.0). Symptoms of CLI were almost
2.6 times as common for subjects with BMI higher than
26.3 kg/m2 compared to subjects with lower record-
ings (ORZ2.6; 95% CIZ1.4–4.9). However, serum
concentrations of HDL–cholesterol (ORZ0.9; 95%
CIZ0.5–1.5), blood glucose (ORZ1.1; 95% CIZ0.6–
1.9), and HbA1c (ORZ1.0; 95% CIZ0.2–4.9) were not
associated with the prevalence of CLI (Table 3).
Potential confounding by smoking, diabetes and
blood factors of the association between theEur J Vasc Endovasc Surg Vol 32, July 2006prevalence of CLI and the different study variables
was assessed in multivariate analyses. However,
adjustment for these variables, either individually or
in combination, did not substantially change any of the
results (data not shown).Discussion
In this cross-sectional study of an unselected popu-
lation of over 20,000 individuals an attempt was made
to estimate the prevalence of CLI and assess the
association between the occurrence of disease and
possible risk factors. Two thousand and five hundred
per million inhabitants had CLI, the prevalence was
similar among men and women, and increased by age
in both genders. We observed positive associations
between the prevalence of CLI and smoking, diabetes
mellitus, angina pectoris, serum triglyceride levels and
body mass index.
The annual case fatality rate for CLI seems fairly
stable at 15–20%.1–3,9,12,23–25 In Norway, the incidence
of CLI has previously been computed to 600–800 per
million per year.16 Thus, our prevalence estimate
appears to correspond well with these numbers
provided the life expectancy on average is about 5
years for patients with CLI. However, a higher
prevalence of CLI among subjects over 70 years of
Table 2. Age-adjusted odds ratio (OR) and 95% confidence interval
(CI) for the prevalence of CLI associated with smoking, diabetes
mellitus, previous myocardial infarction and previous or current
angina pectoris
Variables Women and men
CLI Not CLI OR 95% CI
Smoking habit
Former and never smokers 32 13,288 1.0 Reference
Current smokers 18 6034 1.2 0.6–2.2
Smoking habit
Never smokers 12 6957 1.0 Reference
Former and current smokers 38 12,436 2.3 1.1–4.6
Diabetes mellitus
Not diabetes mellitus 44 19,684 1.0 Reference
Current diabetes mellitus 6 500 4.4 1.9–10.5
Myocardial infarction
Never myocardial infarction 45 19,473 1.0 Reference
Previous myocardial
infarction
4 696 1.8 0.6–5.2
Angina pectoris
Not angina pectoris 46 19,699 1.0 Reference
Previous or current angina
pectoris
4 483 2.7 1.0–7.6
Prevalence of Critical Lower Limb Ischaemia 63age is likely, and inclusion of these subjects would
most likely have contributed to an even higher
frequency of the disease. Thus, the occurrence of CLI
in the present investigation may seem relatively high.
In conformity with previous reports, our findings
support that the prevalence of CLI increases with
age.25–27
Smoking is an important risk factor for peripheral
arterial disease. The risk increases with the number of
cigarettes smoked, and becomes weaker with time
after smoking cessation.28 Furthermore, amputations
are more common in IC patients who have been heavy
smokers.28,29 The presence of CLI before the age of 70
was in our data, however, not significantly higher
among current smokers compared to never and former
smokers. Nevertheless, current and former smokers
combined had a substantially higher prevalence of CLI
compared to never smokers. Our results may, there-
fore, indicate that a large proportion of suspected CLI
subjects had stopped smoking prior to participation in
our study when realizing that they were severely
diseased.17
Diabetes is an independent risk factor for periph-
eral arterial occlusive disease, and smoking appears to
have an additive effect on this risk.26,30–32 In diabetics,
major amputations are up to eleven times more
frequent, and surgical procedures are performed at
an earlier age than in CLI subjects without dia-
betes.13,33–36 In this study, CLI were more than four
times more likely in diabetics compared to the general
population. Diabetes showed the strongest association
with the prevalence of CLI among the investigated risk
factors. However, due to the relatively small number
of patients who had the combination of CLI anddiabetes, our data do not allow firm conclusions on
this point.
We found no association with non-fasting blood
glucose and the prevalence of CLI. Non-fasting
glucose levels may not distinguish well between
diabetics and non-diabetics, and the glucose lowering
treatment in known diabetics will prevent any
association from becoming apparent. HbA1c is the
concentration of glycosylated red blood cells, and the
recording is a good indicator for blood glucose levels
during the last few weeks. Among diabetics, however,
levels of HbA1c were not associated with the
prevalence of CLI. Thus, well regulated diabetics
may share the same risk of developing CLI as diabetics
with poorly regulated glucose concentrations.
For blood lipids there is evidence that peripheral
arterial disease is associated with high levels of total
cholesterol and triglycerides, and our data supports
such findings for CLI.36 Since patients with CLI in the
present study may be regarded as relatively young,
they might have a different lipid profile, compared to
older subjects with this disease. Recent studies have
even shown that high concentrations of HDL–choles-
terol are negatively associated with the prevalence of
IC.13 However, this association was not apparent from
our results.
In cross sectional data the exposure and outcome
variables are measured at the same time, and thus, a
temporal cause and effect relation cannot be firmly
established. Nevertheless, it seems more plausible to
interpret high serum lipids, high BMI, previous or
current angina pectoris, and diabetes mellitus as
elements in the causal pathway of CLI, rather than
the opposite. Thus, one could interpret the presented
associations as possible risk factors for the disease.
A uniform definition of CLI is important for
epidemiological analyses to be comparable over
time. According to the European consensus document
chronic critical leg ischaemia is defined by clinical
criteria like pain and use of analgesics in addition to
objective measurements of ankle (ABPI) or toe systolic
blood pressure.5,8,13,15 Although, measurement of
ABPI may give important information in addition to
the medical history, this test is not easily used in large
epidemiological investigations due to costs and time
consumption. Furthermore, the reproducibility of
blood pressure measurements have proven highly
influenced by the experience of the examiners, and
furthermore, the measurements of ABPI may be
unreliable in diabetics.14,15,19,37 Thus, in large popu-
lation studies, it may be easier to identify CLI on
information about symptoms and clinical signs.
The Fontaine stages grade the severity of lower limb
ischaemia; asymptomatic individuals (stage I),Eur J Vasc Endovasc Surg Vol 32, July 2006
Table 3. Age-adjusted odds ratio (OR) and 95% confidence interval
(CI) for the prevalence of CLI associated with lipids, glucose and
HbA1c levels, and body mass index (BMI)
Variables Women and men
CLI Not CLI OR 95% CI
Total cholesterol (mmol/L)*
Low 16 9600 1.0 Reference
High 34 10,597 1.6 0.9–3.0
HDL–cholesterol (mmol/L)†
Low 26 9979 1.0 Reference
High 24 10,215 0.9 0.5–1.5
Triglycerides (mmol/L)‡
Low 15 10,027 1.0 Reference
High 35 10,170 2.1 1.2–4.0
Glucose (mmol/L)§
Low 20 9030 1.0 Reference
High 30 11,155 1.1 0.6–1.9
HbA1c (%)¶
Low 3 241 1.0 Reference
High 3 245 1.0 0.2–4.9
Body mass index (kg/m2)s
Low 13 10,107 1.0 Reference
High 37 10,073 2.6 1.4–4.9
* Cut-points for high and low values of total cholesterol was 6.
00 mmol/L.
† Cut-points for high and low values of HDL–cholesterol was 1.
40 mmol/L.
‡ Cut-points for high and low values of triglycerides was 1.
51 mmol/L.
§ Cut-points for high and low values of glucose was 5.2 mmol/L.
¶ Cut-points for high and low values of HbA1c was 7.8%.
s Cut-points for high and low values of body mass index was
26.3 kg/m2.
S. A. Jensen et al.64intermittent claudication (stages IIa and IIb), rest pain
(stage III), and trophic lesions (stage IV). For stage III
(rest pain), however, the definition is rather wide, and
may not distinguish well between claudicants (IC)
with occasional nocturnal pain and CLI patients. The
Rutherford classification was primarily constructed to
detect clinical improvement after treatment and
intended for administration by trained personnel.8,16
Grade II (ischaemic rest pain) is more clearly defined
compared to the Fontaine stage III, however, based on
ABPI measurements or pulse palpation. Thus, as both
symptom scores rely on administration by trained
personnel, the general population would most likely
fail to understand the terms included in these
definitions. Further, the additional objective tests
used to verify the diagnosis are not easily used in
large population screenings. We, therefore, decided to
construct a combination of simple questions intended
for self administration.
The currently presented questionnaire was based
only on symptoms and signs of CLI. Subjects with any
form of chronic ischemic pain or trophic ulcers on the
foot were regarded as having CLI. The level of
physical activity was not taken into consideration.
Nevertheless, subjects with sensory neuropathy with-
out ulcers on foot or toes may have escaped detection.Eur J Vasc Endovasc Surg Vol 32, July 2006Further, ulcers of other origins than atherosclerosis
may have been included. Thus, one cannot exclude the
possibility that some patients with venous ulcers in the
gaiter area might have been included in our data.
Finally, discomfort from orthopaedic conditions may
be interchangeable with ischemic pain, but the
questions were designed in an attempt to exclude
these patients by adding the aspect of pain relief while
the foot was dependent. Other disadvantages of the
present study are that the questions had not been
validated against a ‘gold standard’ including history, a
thorough physical examination and measurement of
ABPI. Further, it was impossible to call back subjects
with CLI for a second evaluation due to patient
confidentiality. To compensate for this we investigated
the relation between suspected CLI subjects and risk
factors, which are known to be associated with the
condition. Finally, one cannot exclude the possibility
that subjects with acute limb ischaemia have been
included.
Compared to previous reports from Norway our
data indicate a relatively high prevalence of CLI in a
rather young population.16,38 Thus, with the general
aging of the Norwegian population the number of
patients presenting with CLI may be expected to
increase in the future.
In conclusion, the prevalence of CLI was 0.24%,
similar between the genders, and increased with age.
Risk factors commonly observed in atherosclerotic
patients were found among the suspected CLI subjects
we identified.References
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